Drug Type Biological products |
Synonyms EA 502, EA-502, EA502 |
Action modulators |
Mechanism Complement system proteins modulators(Complement system proteins modulators) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic macular oedema | Preclinical | Global | - |